Authors:
Mahjneh, I
Marconi, G
Bushby, K
Anderson, LVB
Tolvanen-Mahjneh, H
Somer, H
Citation: I. Mahjneh et al., Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations, NEUROMUSC D, 11(1), 2001, pp. 20-26
Authors:
Anderson, LVB
Harrison, RM
Pogue, R
Vafiadaki, E
Pollitt, C
Davison, K
Moss, JA
Keers, S
Pyle, A
Shaw, PJ
Mahjneh, I
Argov, Z
Greenberg, CR
Wrogemann, K
Bertorini, T
Goebel, HH
Beckmann, JS
Bashir, R
Bushby, KMD
Citation: Lvb. Anderson et al., Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies), NEUROMUSC D, 10(8), 2000, pp. 553-559
Authors:
Anderson, LVB
Davison, K
Moss, JA
Young, C
Cullen, MJ
Walsh, J
Johnson, MA
Bashir, R
Britton, S
Keers, S
Argov, Z
Mahjneh, I
Fougerousse, F
Beckmann, JS
Bushby, KMD
Citation: Lvb. Anderson et al., Dysferlin is a plasma membrane protein and is expressed early in human development (vol 8, pg 855, 1999), HUM MOL GEN, 8(6), 1999, pp. 1141-1141
Authors:
Anderson, LVB
Davison, K
Moss, JA
Young, C
Cullen, MJ
Walsh, J
Johnson, MA
Bashir, R
Britton, S
Keers, S
Argov, Z
Mahjneh, I
Fougerousse, F
Beckmann, JS
Bushby, KMD
Citation: Lvb. Anderson et al., Dysferlin is a plasma membrane protein and is expressed early in human development, HUM MOL GEN, 8(5), 1999, pp. 855-861